Learn More
Selleck Chemical LLC Ceritinib dihydrochloride S4967-25mg

Supplier: Selleck Chemical LLC S496725MG
Ceritinib (Zykadia LDK378) dihydrochloride is a selective orally bioavailable and ATP-competitive inhibitor of ALK with IC50 of 0 2 nM Ceritinib dihydrochloride also inhibits InsR IGF-1R and STK22D with IC50 of 7 nM 8 nM and 23 nM respectively Ceritinib exhibits antitomor activity
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.